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The  effects  of Leishmania  mexicana  metacyclic  promastigotes  upon  MAP  kinase  signalling  in mouse  bone
marrow  macrophages  and  subsequent  expression  of  the  disease  regulatory  proteins  iNOS  and  COX-2
were studied.  At a ratio  of 5:1,  promastigotes  caused  a  marked  increase  in  phosphorylation  of  the three
major MAP  kinases,  ERK,  p38  and  JNK.  MAP  kinase  signalling  was  substantially  reduced  in  TLR-4−/−
but  not  TLR-2−/− deficient  macrophages  and completely  abolished  in  double  TLR-2/4−/− macrophages.
A  similar  outcome  was  observed  using  cysteine  peptidase  B  deficient  amastigotes.  Furthermore,  whilst
promastigotes  had  no  independent  effect  on  iNOS  or  COX-2  expression,  they  prolonged  the  induction
of  these  proteins  stimulated  by LPS  and  enhanced  PGE2 and  NO  production.  Induction  of  COX-2  and
iNOS  was  also  TLR-4  dependent.  Blockade  of either  PGE2 or  NO  production  with  indomethacin  or  l-
NAME  reversed  promastigote  inhibition  of  LPS  induced  IL-12  production.  Promastigotes  also  increased
macrophage  arginase-1  expression  and  enhanced  arginase  activity,  both  of  which  were  substantially
reduced  in  TLR-4  but  not  TLR-2  deficient  macrophages.  Surprisingly,  arginase  inhibition  by  Nor-NOHA
also  caused  a reversal  of promastigote  mediated  inhibition  of  macrophage  IL-12  production.  These  data
demonstrate  for  the  first  time  the  role  of  TLR-4  in mediating  the  effects  of  L.  mexicana  promastigotes  on
MAP  kinase  activation,  up-regulation  of  COX-2,  iNOS  as  well  as  arginase-1  expression  in macrophages
and  further  shows  that  PGE2, NO  and  arginase  activity  all contribute  substantially  to  the  inhibition  of
host  cell  IL-12  production.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Leishmania are obligate intracellular parasites transmitted
by sandflies as metacyclic promastigotes that infect primarily
macrophages in the vertebrate host where they transform and mul-
tiply as amastigotes. Depending primarily on the species initiating
infection, they cause a wide range of diseases such as cutaneous,
mucocutaneous and visceral leishmaniasis in humans throughout
the mediterranean, sub-tropical and tropical regions of the globe.
Protective immunity is generally associated with an IL-12 driven
type-1 response and IFN- production whilst non-healing disease
is associated with a deficient type-1 response. Many studies now
indicate an inability to produce or respond to IL-12 as the primary
default mechanism leading to non-healing disease (reviewed by
∗ Corresponding author. Tel.: +44 0141 5484286; fax: +44 0141 552 2562.
E-mail address: r.plevin@strath.ac.uk (R. Plevin).
McMahon-Pratt and Alexander, 2004) and it is well established is
that Leishmania promastigotes and amastigotes of all species stud-
ied to date are able to significantly inhibit the IL-12 production
associated with host cell activation (reviewed by Kima, 2007).
The intracellular mechanisms through which Leishmania
species regulate cellular responses, including IL-12 production, in
macrophages and other host cells, remain unclear despite consider-
able study (Olivier et al., 2005). Nevertheless, a number of divergent
effects are apparent, dependent upon parasite species, the life-
cycle stage of the parasite (promastigote versus amastigote) and
the cellular target. For example, host cell IL-10, generated via Fc
receptor mediated uptake of opsonised parasites, has been shown
to play a significant role in downregulating IL-12 production (Kane
and Mosser, 2001; Thomas and Buxbaum, 2008). Furthermore,
enhanced PGE2 production, mediated in part via parasite COX-2
induction (Matte et al., 2001; Reiner and Malemud, 1985) is also
capable of inhibiting macrophage IL-12 although this has yet to be
specifically demonstrated at the level of the infected macrophage.
0161-5890/$ – see front matter ©  2011 Elsevier Ltd. All rights reserved.
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A similar inhibition of IL-12 action has also been demonstrated for
nitric oxide (Huang et al., 1998), but few studies demonstrate if
endogenous macrophage NO induced by the parasite infection is
sufficient to promote this effect. Indeed, studies show inhibition
of IL-12 production independently of these pathways (Weinheber
et al., 1998); Leishmania mexicana and the related Leishmania ama-
zonensis can directly mediate degradation of NFB (Cameron et al.,
2004) and JAK/STATs (Xin et al., 2008), key signalling pathways
which regulate IL-12 transcriptional activity. These effects are asso-
ciated with expression of parasite-derived cysteine peptidase B
(CPB) (Abu-Dayyeh et al., 2010; Cameron et al., 2004) or surface
molecules such as lipophosphoglycan (LPG) (Balaraman et al., 2005;
Feng et al., 1999). However the mechanisms and pathways of reg-
ulation are not yet well defined.
Recently, a major role for toll-like receptors (TLRs) has been
implicated in the actions of some Leishmania species. These studies
indicate important roles for TLR-2 ligation and MyD88 in the con-
trol of infection with Leishmania major (de Veer et al., 2003; Kavoosi
et al., 2010) and Leishmania braziliensis (Vargas-Inchaustegui et al.,
2009), TLR-4 in control of L. major (Kropf et al., 2004a,b) and
Leishmania pifanoi (Whitaker et al., 2008) and TLR-9 in control-
ling Leishmania donovani, L. major and L. braziliensis (Liese et al.,
2007; Schneider et al., 2007). However, very few of these studies
have assessed the cellular consequences of TLR engagement. Thus,
whilst CPB deficient amastigotes (Cameron et al., 2004) as well as
promastigotes (Lapara and Kelly, 2010; Ruhland and Kima, 2009)
remain able to inhibit IL-12 production by activated host cells, it
is possible that engagement of TLRs may  be able to explain these
effects (Vargas-Inchaustegui et al., 2009).
We show here that promastigotes activate MAP  kinase sig-
nalling through a TLR-4 dependent mechanism to prolong COX-2
and iNOS expression and enhance PGE2 and NO production. This
effect is mimicked by cysteine peptidase B deficient amastigotes.
These mediators both function to subsequently down regulate
IL-12 production. Furthermore, promastigotes enhance arginase-
1 expression and activity again via a TLR-4 dependent pathway
that also, unexpectedly, participates in negatively regulating
IL-12 production. These data elucidate for the first time the
multiple pathways simultaneously targeted by L. mexicana pro-
mastigotes and by implication amastigotes to inhibit production
of IL-12.
2. Materials and methods
2.1. Medium and reagents
All cell culture reagents were from Invitrogen (Paisley, UK) and
Cambrex BioScience (Veniers, Belgium). TC100 insect medium and
LPS (from Salmonella abortus) were from Sigma (Poole, UK). Recom-
binant murine IL-4 was from BD Pharmingen (TM, USA). l-Arginine,
Triton X-100, pepstatin A, aprotinin and antipain hydrochlo-
ride were from Calbiochem, UK. -Isonitrosopropiophenone was
obtained from Sigma (Poole, UK). MAP  kinase and NF-B (p65 iso-
form) antibodies were from Santa Cruz Biotechnology (CA, USA)
and rabbit polyclonal anti-iNOS and anti COX-2 antibodies from
Cayman Chemicals (Michigan, USA). Detection of arginase-1 used
mouse monoclonal anti-arginase1 (BD, Drogheda, Ireland). The
TLR-2, TLR-4 and TLR-2/4 deficient mice on a C57Bl6 background
were obtained from Professor Akira S. Osaka University, Japan.
2.2. Parasites
L. mexicana (MNYC/BZ/62/M379) promastigotes were cultured
in 25 cm3 culture flasks (IBS) in TC100 insect medium supple-
mented with 10% (v/v) FCS. The promastigotes were incubated
at 26 ◦C for seven days, until the metacyclic stage was achieved.
Amastigotes of cysteine peptidase B (CPB)-deficient mutants
(cpb) used in this study have been described previously (Cameron
et al., 2004). Parasites were washed in RPMI at least three times
before use.
2.3. Generation of bone marrow-derived macrophages (BMM)
and infection
Bone marrow cells were obtained by flushing the femurs of
C57BL/6 mice. Cells were cultured in DMEM, containing 10% (v/v)
heat-inactivated FCS 30% (v/v) and L cell-conditioned medium.
Once cells had become confluent after approximately 8–10 days,
they were harvested by scraping into 5 ml of cold, sterile RPMI
1640 medium. The cell suspension was  then washed three times;
cells were diluted to the appropriate cell number using complete
RPMI media and seeded in plates. These were then incubated at
33 ◦C/5% CO2 overnight to allow the cells to adhere to the plate.
Cells were then stimulated, in a final volume of 500 l, with LPS,
IL-4 and/or with L. mexicana stationary phase metacyclic pro-
mastigotes harvested from in vitro cultures or lesion-derived CPB
deficient amastigotes purified from infected mice (Cameron et al.,
2004). A ratio of 5:1, parasite: macrophage was used except where
indicated.
2.4. SDS-PAGE and Western blot analysis
Cells were exposed to vehicle or appropriate agonists for the rel-
evant period of time. They were then washed twice with ice cold
PBS before adding 200 l of pre-heated Laemmli’s sample buffer.
The cells were then harvested with a rubber policeman and the
chromosomal DNA sheared by repeatedly passing through syringe
with a 21 gauge needle in sterile Eppendorf tubes. The tubes were
boiled for 5 min  to denature proteins and samples were stored
at −20 ◦C until use. Proteins were separated on a 10% (for detec-
tion of MAPKs and arginase), 8.5% (for detection of COX-2) or 7.5%
(for detection of iNOS) SDS-PAGE gel. The proteins separated by
SDS-PAGE were transferred to nitrocellulose membranes by elec-
trophoretic blotting following a standard protocol (Towbin et al.,
1979). Proteins were identified as outlined previously using specific
antibodies (Cameron et al., 2004).
2.5. Measurement of arginase activity
Murine BM-macrophage arginase activity was determined using
an assay based on a reaction with -isonitrosopropiophenon (ISPF),
as previously described previously (Corraliza et al., 1994). Briefly,
cells were harvested and lysed with 50 l of 50 mM Tris–HCl
buffer, pH 7.4, containing 0.1% Triton X-100, 5 g/ml pepstatin
A, 5 g/ml aprotinin, 5 g/ml antipain and MnCl2 10 mM,  pH
7.4. Arginine hydrolysis was performed by incubating the lysate
with 25 l of 0·5 M l-arginine (pH 9.7) at 37 ◦C for 60 min. The
reaction was stopped by adding 400 l of an acid solution con-
taining H2SO4, H3PO4 and H2O in a ratio of 1:3:7 was  added,
along with 25 l of a 9% solution of ISPF. The acid mixture and
ISPF were also added to 100 l aliquots of urea standards. Sam-
ples and standards were incubated at 95 ◦C for 45 min, and then
allowed to cool for 10 min  in darkness. Aliquots (200 l) were
added to wells of a 96 well plate and absorbance read at 540 nm
on a Spectromax 190 plate reader. Arginase activity of the sam-
ples was calculated by comparison to a standard curve generated
from known quantities of urea. One unit of arginase activity was
defined as the enzyme activity that catalysed the production of
1 Mol  urea/min.
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Fig. 1. Promastigotes and cpb amastigotes mediate increased MAP kinase signalling in macrophages. Cells (1 × 106/well) were infected with L.mexicana promastigotes
(A–C)  or cpb amastigotes (D-F) (ratio, 5:1) for the times indicated. Whole cell lysates were prepared, separated by SDS-PAGE, and then assessed for p-JNK1/2 and T-JNK
(A  and D), p-ERK1/2 and T-ERK (B and E) p-p38 MAPK and T-p38MAPK (C and F) as outlined in Section 2. The results are representative of 3 independent experiments with
similar  findings.
2.6. NO release in infected BMM
The supernatant of cell culture medium was collected for NO
analysis. Quantification of NO production, by measuring nitrite (a
stable metabolite of NO) levels, was as previously described (Tsai
et al., 1999). To 50 l of well supernatant, 50 l of Griess reagent
(equal volumes of 2% (w/v) sulphanilamide in 5% (v/v) H3PO4 and
0.2% (w/v) naphylethylenediamine HCl in water) was added. After
incubation for 10 min  at room temperature in darkness, absorbance
was read at 540 nm on a Spectromax 190 plate reader. Nitrite
production was determined by comparison to a standard curve
generated using known concentrations of NaNO2.
2.7. Macrophage cytokine detection
The concentration of IL-12 (p70/p40) present in cell cul-
ture supernatants was assayed by a two-site enzyme linked
immunosorbant assay (ELISA) for murine rIL-12 (R&D Systems,
Abingdon, UK). The concentration of PGE2 present in cell culture
supernatant was measured by ELISA for Murine rPGE2 (R&D Sys-
tems, Abingdon, UK).
2.8. Statistical evaluation
Densitometry data generated from immunoblots was expressed
as mean ± SEM for at least 3 separate experiments. The statistical
significance of differences between mean values from control and
treated groups were determined by the one-way analysis of vari-
ance (ANOVA) using GraphPad Prism® Version 4.0 software or one
tailed Student’s Unpaired t-test. p < 0.05 was accepted as significant.
3. Results
3.1. Regulation of signalling pathways following Leishmania
mexicana promastigote infection
Having previously established a negative effect of L. mexicana
amastigotes on kinase signalling pathways mediated by amastig-
ote expressed CPB (Cameron et al., 2004) we tested the ability of
promastigotes from the same species to modulate these pathways
in mouse bone marrow derived macrophages. Alone, addition of
promastigotes (5:1) resulted in a strong activation of MAP  kinase
signalling, with JNK activation apparent by 15 min  after promastig-
ote addition. ERK activation was more rapid but less sustained in
comparison to JNK coming back to basal by 60 min, whilst p38
MAP  kinase was rapidly induced and sustained for the full time
course (Fig. 1A–C). Promastigotes alone also stimulated NFB  acti-
vation as assessed by cellular IB loss and the phosphorylation
of p65 (Supplementary Fig. S1). However, pretreatment of mouse
bone marrow derived macrophages with promastigotes had minor
effect upon LPS induced signalling, and there was  little consis-
tent enhancement of MAP  kinase phosphorylation (pERK, pp38 and
pJNK) and NFB activation (Supplementary Fig. S2).
We  also sought to determine if cellular activation of MAP  kinase
was  dependent upon either life cycle stage or the presence of the
enzyme CPB which we  have previously shown to degrade MAP
kinases (Cameron et al., 2004). For this reason we used cpb
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Fig. 2. Promastigote activation of the MAP  kinases is mediated by TLR-4.
Macrophages derived from wild type (WT), TLR-2−/− , TLR-4−/− or TLR-2/4−/− mice
(1  × 106/well) were infected with L. mexicana promastigotes (ratio, 5:1) or LPS for
the times indicated. Whole cell lysates were prepared, separated by SDS-PAGE, and
then assessed for (A) p-JNK1/2 (46/54 kDa) and T-JNK, (B) p-ERK1/2 (44/42 kDa) and
T-ERK (C) p-p38 MAP  kinase and T-p38MAPK. The results are representative of 3
independent experiments with similar findings.
amastigotes at the same ratio (5:1). Addition of cpb amastigotes
to bone marrow derived macrophages also stimulated a similar
rapid activation of the MAP  kinase pathway, increasing the phos-
phorylation of JNK, ERK, p38 MAP  kinase in a manner similar to
promastigotes (Fig. 1D–F). Similar results were observed at the level
of cellular IB loss and phosphorylation of p65 NFB (not shown).
Thus, L. mexicana infection of macrophages results in a marked
increase in signalling events linked to innate immunity, but these
changes are a component part of the parasite irrespective of the life
cycle stage.
3.2. Requirement for TLR-4 in activation of macrophages by L.
mexicana promastigotes
Recent studies have shown the potential for L. major to activate
TLR-2 (de Veer et al., 2003; Kavoosi et al., 2010) and TLR-4 (Kropf et
al., 2004a,b). We  therefore compared MAP  kinase signalling follow-
ing L. mexicana promastigote infection in macrophages deficient in
TLR-2 and TLR-4 or both (Fig. 2). In macrophages from wild type
mice, L. mexicana promastigotes stimulated an increase in phos-
phorylation of all three MAP  kinases, JNK (Panel A), ERK (Panel B)
and p38 MAP  kinase (Panel C), confirming our previous observa-
tions. Activation of MAP  kinase signalling was only slightly reduced
in TLR-2−/− macrophages. However, in TLR-4−/− macrophages,
phosphorylation of all three MAP  kinases were markedly affected,
ERK and JNK phosphorylation was essentially abolished whilst
p38 MAP  kinase was significantly reduced. This residual activa-
tion of p38 MAP  kinase is unclear but could be a consequence of
entry of the pathogen, an effect which we have noted previously
for Salmonella (Royle et al., 2003). A similar pattern of sensitiv-
ity was observed for LPS induced kinase signalling, confirming
Fig. 3. TLR-4 mediates cpb amastigote activation of MAP kinases. Macrophages
derived from wild type, TLR-2−/− , TLR-4−/− or TLR-2/4−/− mice (1 × 106/well) were
infected with L.mexicana cpb amastigotes (ratio, 5:1) for the times indicated.
Whole cell lysates were prepared, separated by SDS-PAGE, and then assessed for
(A)  p-JNK1/2 (46/54 kDa) and T-JNK (B) p-ERK1/2 (44/42 kDa) and T-ERK (C) p-p38
MAPK and T-p38 MAPK. The results are representative of 3 independent experiments
with similar findings.
the predicted pattern of sensitivity for a known TLR-4 ligand. We
did however observe a residual effect in TLR-4−/− macrophages
particularly in response to LPS, this is likely due to contaminat-
ing fragments which are able to activate TLR-2. Nevertheless, in
TLR-2/4−/− macrophages, MAP  kinase signalling in response to L.
mexicana was completely abolished. A similar TLR-4 dependency
was  observed for cpb amastigote stimulation of MAP  kinase sig-
nalling (Fig. 3) suggesting a stage-independent activation. Thus,
activation of macrophages by L. mexicana promastigotes is largely
through a TLR-4 dependent pathway, with a neglible role for TLR-2
signalling.
3.3. Leishmania mexicana promastigotes enhance COX-2 and
iNOS expression in a TLR-4 dependent manner
We next examined functional expression of COX-2 and iNOS,
two  downstream events linked to TLR signalling (Fig. 4). Infec-
tion with promastigotes alone did not induce macrophage COX-2
or iNOS protein expression at any time point (data not shown).
However, infection of macrophages with L. mexicana promastig-
otes prolonged the kinetics of protein expression induced by LPS
such that after 24 h when LPS induced responses waned, COX-2
and iNOS expression was maintained for a further 48 h by the pres-
ence of promastigotes (Fig. 4A and C). Concomitant to increased
COX-2 and iNOS expression, PGE2 and NO release were similarly
enhanced by promastigote infection particularly at the 24 and 48 h
time points (Fig. 4B and D). Control experiments indicate that this
was  not dependent upon enhanced activation of IRF-3 phosphory-
lation known to be a key component of TLR-4 induction of iNOS.
Whilst LPS enhanced IRF-3 phosphorylation this was not further
modified by the presence of promastigotes (Supplementary Fig. S3).
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Fig. 4. Promastigotes prolong LPS induced COX-2 and iNOS expression. Cells
(1  × 106/well) were infected with L. mexicana promastigotes (ratio, 5:1) for 2 h and
then stimulated with LPS (1 g/ml) for the times indicated. Whole cell lysates were
prepared, separated by SDS-PAGE, and then assessed for COX-2 (Panel A) or iNOS
(Panel C) as outlined in Section 2. In Panels B and D, supernatants were collected and
assessed for PGE2 or nitrate accumulation respectively. Each value represents the
mean ± S.E.M. The results are representative of at least 3 independent experiments
with similar findings. * and ** indicates p < 0.05 and 0.01 compared to LPS alone.
Nevertheless, the enhancing effect of promastigotes on LPS
induced macrophage COX-2 and iNOS expression were again
dependent upon TLR-4 activation (Fig. 5). In TLR-2−/− macrophages,
the reduction in signal was marginal, however in TLR-4−/−
macrophages expression of COX-2 was substantially although
not completely reduced. In addition, iNOS expression was
essentially abolished in TLR-4−/− deficient macrophages. In
macrophages derived from TLR-2/4−/− mice, both COX-2 and
iNOS signals were abolished. A similar result was obtained for
cpb amastigotes (results not shown). Thus early activation of
MAP kinase signalling through TLR-4 reflects a similar recep-
tor dependency at the level of downstream iNOS and COX-2
expression.
Fig. 5. TLR-4 mediates sustained iNOS and COX-2 in response to promastigotes.
Macrophages derived from wild type (WT), TLR-2−/− , TLR-4−/− or TLR-2/4−/− mice
(1  × 106/well) were infected with L.mexicana promastigotes (ratio, 5:1) for 2 h and
then stimulated with LPS (1 g/ml) for 24 h. Whole cell lysates were prepared, sep-
arated by SDS-PAGE, and then assessed for COX-2 (Panel A) or iNOS (Panel B) and
T-p38 MAPK as outlined in Section 2. The results are representative of at least 3
independent experiments with similar findings.
3.4. L. mexicana promastigote inhibition of macrophage IL-12
production is a result of prolonged PGE2 and NO induction
In order to determine the functional consequences of prolonged
macrophage NO and PGE2 formation induced by promastigotes
through TLR-4, we  examined the inter-relationship with IL-12 pro-
duction. We  have previously demonstrated that amastigotes inhibit
IL-12 in significant part due to CPB mediated degradation of the
NFB pathway (Cameron et al., 2004). Pre-infection of macrophages
with promastigotes, which lack the high levels of CPB found in
amastigotes, prior to LPS treatment also abolished IL-12 production
(Fig. 6, Panels A and B). Inhibition proved to be cytokine specific
as LPS induction of TNF, IL-1, IL-6 or IL-10 was not affected
(Supplementary Fig. S4). However, we also found that addition of
the COX-2 inhibitor indomethacin at 6 h subsequent to LPS, sub-
stantially reversed the effect of promastigotes on macrophage IL-12
production after 24 h (Panel A). Interestingly, pretreatment with a
non-selective NOS inhibitor l-NAME which abolished NO release
(not shown) also reversed the inhibitory effect of promastigotes on
macrophage IL-12 production (Panel B).
3.5. L. mexicana promastigotes induce macrophage arginase-1
expression and activity which also downregulates IL-12
production
We also examined whether TLRs 2 and 4 were involved in
other pathways which may  mediate the actions of promastigotes
upon macrophage function (Fig. 7). Consistently we found that pro-
mastigotes alone were sufficient to induce arginase-1 expression
and activity, as well as enhancing LPS or IL-4-induced arginase-1
(Panels A and B). By contrast, induction of arginase-1 by promastig-
otes was  substantially reduced in TLR-4−/− macrophages but not in
macrophages derived from TLR-2−/− mice (Panel C). In TLR-2/4−/−
macrophages arginase-1 levels were reduced even further to below
the control base line. This was  also reflected at the level of arginase
activity (Panel D). Neither promastigotes nor LPS induced measur-
able macrophage arginase activity in the absence of TLR-4 and no
additive effects were observed between these agents. Furthermore,
whilst IL-4 was  still able to induce arginase, there was  no additive
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Fig. 6. Prevention of PGE2 and NO formation reverses promastigote inhibition of
IL-12 production. Cells (1 × 106/well) were infected with L.mexicana promastigotes
(ratio, 5:1) for 2 h and then stimulated with LPS (1 g/ml) for 6 h. Indomethacin
(30  M)  or l-NAME (1 mM)  was then added and cells incubated for a further 18 h.
Samples were assessed for IL-12 production as outlined in Section 2. Each value
represents the mean ± S.E.M. of at least 3 experiments performed in triplicate, ***
indicates p < 0.05 compared to LPS alone.
effect with either promastigotes alone or in combination with LPS
(Panel D).
Finally, we sought to determine if arginase induction mediated
by promastigote infection could regulate the interplay between
NO and IL-12 production (Fig. 8). Macrophages were pre-infected
with promastigotes and then stimulated with LPS prior to addi-
tion of the arginase inhibitor, nor-NOHA (50 M).  When cells were
treated with the arginase inhibitor, this substantially increased the
release of NO in response to LPS in combination with promastig-
otes, indicating that arginase activity limits the levels of NO within
the macrophage. Surprisingly, the intervention at this concentra-
tion which enhanced NO release, also reversed the inhibitory effect
of promastigotes on IL-12 production (Panel B). Similar results were
obtained with cpb amastigotes (results not shown).
4. Discussion
In order to successfully parasitize the vertebrate host Leishma-
nia species, such as L. mexicana (Rodriguez-Sosa et al., 2001), must
subvert the innate inflammatory response of host cells that results
in the IL-12 production that is pivotal in initiating the development
of type-1 protective immunity. Our present studies highlight novel
and multiple mechanisms utilized by L. mexicana promastigotes as
well as amastigotes to modulate host cell intracellular signalling
functions to achieve this objective. We  find that promastigotes and
also CBP deficient null mutant amastigotes, by utilizing a TLR-4
dependent mechanism, mediate the phosphorylation of ERK, p38
and JNK to enhance LPS induced macrophage iNOS and COX-2
expression and in addition, enhance arginase-1 expression in naïve
as well as activated host cells. Furthermore, we clearly demonstrate
using specific inhibitors that the activities associated with all three
enzymes down regulate macrophage IL-12 production. Overall our
data sheds significant new light on how the “mexicana complex”
parasites modulate host cell function to subvert the induction of
protective immunity.
Our initial experiments demonstrated a pattern of kinase acti-
vation in response to promastigotes which mimicked closely
responses following TLR engagement and reflected some of the
characteristics of kinase activation demonstrated by some other
Leishmania species (Ben-Othman et al., 2008). Our experiments,
however, revealed precisely the TLR, which mediates the effects
of promastigotes on MAP  kinase signalling, namely TLR-4. TLR-4
is linked to both the MAP  kinase pathway and NFB  through the
activation of MyD88 signalling, a model consistent with the pro-
file of kinase activation recorded in this paper (O’Neill et al., 2009).
Recent studies have implicated a role for TLR-dependent events
in the actions of Leishmania species including TLR-2 (Becker et al.,
2003), TLR-4 (Kropf et al., 2004a)  and MyD88 (Vargas-Inchaustegui
et al., 2009). Although there is evidence that TLR-2 may  play a regu-
latory role during infection with L. braziliensis (Vargas-Inchaustegui
et al., 2009) and downregulate DC IL-12 production, all other stud-
ies implicate TLRs and TLR-4 ligation and MyD88 signalling in
particular in the generation of protection against infection. Inter-
estingly, we also demonstrate activation of MAP  kinase in response
to infection with cpb amastigotes, again through a TLR-4 depen-
dent mechanism. This suggests that irrespective of the life cycle
stage, L. mexicana has the ability to engage with a pathogen recogni-
tion receptor. For amastigotes this is significant if we also consider
that this stage, which normally express the enzyme CPB, has as a
primary mechanism of action, the degradation of intracellular sig-
nalling proteins such as NFB intermediates and the MAP  kinases
(Cameron et al., 2004). Thus, we have revealed that amastigotes
can regulate MAP  kinase signalling in two  ways, one positively
through TLR-4 engagement, the other negatively via degradation
of intracellular kinases.
We also observed effects of promastigotes upon macrophage
iNOS and COX-2 expression downstream of MAP  kinase signalling.
Although infection with promastigotes alone was not sufficient
to induce either protein, it resulted in a prolonged induction of
both COX-2 and iNOS in response to LPS stimulation and enhanced
macrophage PGE2 and NO release over an extended period. This
effect was dependent upon TLR-4 activation, the first time reg-
ulation of COX-2 and iNOS has been described for L. mexicana
promastigotes via this receptor. It was  surprising that promastig-
otes were unable to increase iNOS and COX-2 per se, since TLR-4
ligation is sufficient to do this (O’Neill et al., 2009), however lower
levels of receptor occupancy may  be a factor. Also it is possible
that promastigotes may  have differential effects on other pathways
required for iNOS and COX-2 production such as NFB and IRF-3
(O’Neill et al., 2009). Indeed our studies have shown promastigotes
do not enhance IRF3 phosphorylation, a key event in iNOS expres-
sion induced in response to LPS (O’Neill et al., 2009). Thus some
other mechanism must be responsible for the effects observed in
this paper.
Enhancing PGE2 release through prolonged COX-2 expression
would be an outcome consistent with studies showing PGE2 to be a
virulence factor (Guimaraes et al., 2006); exogenous PGE2 increases
L. amazonensis parasite load in BALB/c macrophages (Pinheiro et al.,
2009) and indomethacin treatment in vitro enhances IL-12 and IFN-
 production from splenocytes derived from L. mexicana infected
BALB/c mice (Perez-Santos and Talamas-Rohana, 2001). Indeed
prevention of PGE2 release by treatment with indomethacin subse-
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Fig. 7. Promastigotes increase arginase-1 expression and activity by a TLR-4 dependent mechanism. Cells (1 × 106/well) from WT  (Panels A–C), or TLR-4−/− mice (Panels C
and  D) were infected with L.mexicana promastigotes (ratio, 5:1) for 2 h and then stimulated with LPS or IL-4 for 24 h. Arg-1 expression (Panels A and C) or activity (Panels
B  and D) was  measured as outlined in Section 2. The results are representative of 3-independent experiments with similar findings. Where indicated each value represents
the  mean ± S.E.M. *, ** indicates p < 0.05 or 0.01 compared to LPS alone.
quently reversed the inhibition of macrophage IL-12 production by
promastigotes indicating that enhanced COX-2 expression is func-
tionally relevant in the actions of L. mexicana. Although a number
of previous studies demonstrate that exogenous PGE2 can reduced
macrophage IL-12 production (Iwasaki et al., 2003; Monteleone
et al., 1999), few focus on endogenous production following Leish-
mania infection and this is one of the first studies which relates
sustained PGE2 production induced by any Leishmania species to
an effect upon IL-12 production within the same macrophage. This
may  be related to the fact that Leishmania infection per se may  not be
sufficient to induce COX-2 expression and an additional stimulus is
required (Farrell and Kirkpatrick, 1987). In mammary carcinomas,
production of PGE2 is markedly increased resulting in inhibition of
endogenous IL-12, an effect which can be reversed by non-selective
blockade of COX activity (Mitsuhashi et al., 2004).
Prevention of NO production also significantly reversed the inhi-
bition of IL-12 by promastigotes. This is consistent with studies
which show that pharmacological or genetic modulation of NO lev-
els can regulate IL-12 production (Boddupalli et al., 2007; Huang
et al., 1998; Xiong et al., 2004). Although increase in NO levels is
usually associated with parasite killing the fact that in this present
study promastigotes enhanced NO formation would appear to be
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Fig. 8. Arginase blockade reverses promastigote mediated inhibition of IL-12 pro-
duction. Cells (1 × 106/well) were infected with L. mexicana promastigotes (ratio,
5:1) for 2 h, then stimulated with LPS (1 g/ml) for 6 h prior to the addition of
nor-NOHA (50 M)  for a further 18 h. Samples were assessed for IL-12 produc-
tion as outlined in Section 2. Each value represents the mean ± S.E.M. of at least
3  experiments performed in triplicate. *** indicates p < 0.05 compared to LPS alone.
paradoxical. However, studies show that promastigotes (Gomes
et al., 2003) and amastigotes (Mukbel et al., 2007) from L. amazonen-
sis,  a “mexicana complex” parasite, are more resistant to NO than L.
major. Recent evidence indicates that, unlike L. major,  there is in fact
enhanced replication of the amastigote stage of L. amazonensis in
IFN--stimulated murine macrophages despite increased NO pro-
duction (Wanasen et al., 2007). The evidence would suggest that
macrophage killing of L. amazonensis unlike L. major requires NO
and additionally, superoxide (Mukbel et al., 2007). Consequently a
certain level of NO induction by L. mexicana complex parasites need
not be detrimental to the parasite but in fact could actually promote
infection by inhibiting IL-12 production and the development of a
protective type-1 response.
Induction of arginase by L. amazonensis has also been shown to
enhance replication of the amastigote state of the parasite (Qi et al.,
2004; Wanasen et al., 2007) whilst arginase activity is also associ-
ated with susceptibility to L. major infection in BALB/c mice (Kropf
et al., 2005). Our studies also revealed the potential for L. mexi-
cana promastigotes to be involved in the regulation of arginase-1
expression in the macrophage through TLR-4. This finding is differ-
ent from a study which demonstrates that in TLR-4 deficient mice
arginase activity in response to L. major is enhanced, implicating
that TLR-4 negatively controls arginase-1 induction (Kropf et al.,
2004a). Other studies, whilst assessing TLR involvement in Leish-
mania host-cell function have not examined coupling to arginase-1
expression. Recently TLR-2 has been implicated in arginase expres-
sion and pathogenicity in response to Mycobacterium tuberculosis
or Toxoplasma gondii (El Kasmi et al., 2008) with protective immu-
nity being thwarted by reduced NO production. However, a recent
study in bone marrow derived macrophages has demonstrated
TLR-4 ligation via LPS to enhance both nos-2 and arg-1 expres-
sion and NO and arginase activities (Menzies et al., 2010) which
would be consistent with L. mexicana promastigotes utilizing TLR-
4 as shown in this present study. Consequently, our results reveal
crucial differences in the utilization of TLRs in regulating arginase
in response to different pathogens. We  also elucidated the involve-
ment of arginase in the cellular responses to promastigotes, in
particular regulation of IL-12 production. This intriguing result is
consistent with a recent study that has linked arginase expression
to inhibition of IL-12 production during Schistosoma mansoni infec-
tion (Herbert et al., 2010). Nevertheless, consistent with arginase
and iNOS competing for the same substrate l-arginine inhibition
enhanced NO production which should function to reduce IL-12,
but surprisingly, did not. This paradox suggests potential differ-
ences in the ability of each intermediate to negatively regulate IL-12
production; arginase being implicated as more potent/efficacious
than NO. Overall our data would suggest that L. mexicana pro-
mastigotes and CPB deficient amastigotes, through TLR-4, are able
to prolong and enhance PGE2, NO and arginase production all of
which limit macrophage IL-12 production and subvert the induc-
tion of type-1 protective immune responses. These data elucidate
for the first time the multiple pathways simultaneously targeted
by L. mexicana promastigotes to inhibit production of IL-12.
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Glossary
COX-2: cyclooxygenase-2
ERK: extracellular regulated kinase
iNOS: inducible nitric oxide synthase
IL: interleukin
JNK: c-jun N-terminal kinase
MAP  kinase: mitogen-activated protein kinase
NO: nitric oxide
PGE2: prostaglandin E2
Nor-NOHA: N-hydroxy-nor-arginine
M.O.I.: multiplicity of infection
TLR-4: toll-like receptor-4.
